Navigation Links
Bend Research Announces New Chief Financial Officer

BEND, Ore., Oct. 20, 2011 /PRNewswire/ -- Bend Research Inc. (, a leading independent drug-formulation development and manufacturing company, has announced that John McLeod has joined the company as Chief Financial Officer.

(Photo: )

McLeod was formerly Director of Business Development with Mt. Bachelor Ski Resort for six years, where his strategic vision is credited with improving many different parts of the organization, including new information technologies and streamlined financial systems.

"John is the perfect person to join Bend Research at this time," said Rod Ray, Chief Executive Officer of Bend Research. "Over the last few years we've been changing our business model to one that works with multiple clients. Now that the transition has been successfully completed, we have turned our attention to strategic growth. John has the financial management skills and insights we need to move the company forward."

In addition to being a member of the management team, McLeod will be responsible for oversight of all accounting and information technology functions within the company.

McLeod is originally from Sydney, Australia, and lived in Europe and Asia before moving to the United States. He earned a bachelor's degree in economics from Macquarie University and a master's degree in business administration from the University of New England (both in Australia). McLeod is a certified public accountant and is active in community organizations. He currently serves on the board of Central Oregon Intergovernmental Council (COIC), and was formerly the tourism representative to Economic Development for Central Oregon (EDCO).

"Bend Research is at a very exciting point in its history and I am looking forward to contributing to the success and growth of another great Central Oregon company," said McLeod. "And the view of the Cascades from my office in Tumalo is almost as good as it was from Mount Bachelor."

About Bend Research Inc.

For more than 35 years, Bend Research has worked with clients to create value to solve their most difficult scientific and technical problems and advance new medicines that improve human health. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies, which grow from a solid base of scientific and engineering fundamental understanding.

Bend Research advances promising drug candidates from conception through commercialization by providing formulation and dosage-form support, assisting in process development and optimization, and manufacturing clinical-trial quantities of drug candidates in its cGMP facilities. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

Bend Research has more than 240 employees based in four state-of-the-art facilities in Bend, Oregon, USA.

SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SANYO Offers Researchers Energy-Efficient, Space-Saving Solutions for Biological Sample Preservation
2. Clinical Research Sites Honor Top Sponsor, CRO and IRB at 2011 Site Solutions Summit
3. VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How
4. SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development
5. Rock Creek Pharmaceuticals Announces Expanded International Shipping Options for Anatabloc™, Physician Conferences on Anatabine Research
6. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
7. Bend Research Announces Schedule of Events at 2011 AAPS Annual Meeting and Exposition
8. VisionSpring Research Finds Seeing to be the Most Important of Five Senses
9. Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers
10. Elsevier Offers 950 New Health Titles to Research4Life
11. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... Association meeting in Washington D.C. revolved around the fact that proper dental care, both ... talk stressed the link between periodontal disease (more commonly referred to as gum disease) ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... , ... The print component of “Supporting Our Caregivers” is ... York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an ... social media strategy and across a network of top news sites and partner ...
Breaking Medicine News(10 mins):